Method for establishing porphyria cutanea tarda (PCT) transgenic mouse model
A technology for transgenic mice and porphyria, applied in genetic engineering, plant genetic improvement, botany equipment and methods, etc., can solve the problems of heme oxidase-1, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0017] With reference to the accompanying drawings, the following embodiments are only used to illustrate the present invention without limiting the scope of the present invention.
[0018] 1. Obtain the target gene:
[0019] Primers were designed to amplify the HO-1 gene sequence in the mouse genome and cloned into pCAGG vector. HO-1 cDNA is initiated by chicken β-actin promoter and CMV enhancer, and HO-1 is connected with rabbit β-globin poly(A) termination signal ( figure 1 ). The plasmid was digested with SalI and DraI to obtain the linear transgene sequence, which was purified and recovered for microinjection.
[0020] 2. HO-1 was introduced into BDF-1 mouse fertilized eggs by microinjection and the production of positive mice
[0021] The linearized target gene fragment is injected into the pronucleus of BDF-1 mouse fertilized eggs to integrate with the mouse genome, and each cell will carry the fragment as the cells continue to divide. Three weeks after the pups wer...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 